You are hereJaipur


Join MBA Programs at GISMA Business School, Germany

GISMA Business School, located in the heart of Hannover, Germany, is an international Business School offering campus-based business education to students from over 40 countries.
GISMA Business School is closely affiliated with Global University Systems (GUS), a consortium of 8 educational institutions, and is internationally accredited by AMBA. All courses at GISMA are taught in English, as the world’s foremost language for business and global communication. Our alumni come from as many as 40 different nations and are taught by professors of diverse cultural backgrounds.


Our AMBA-accredited Programmes

1) MBA:
Become more than a business leader. Become a leader with a global viewpoint and practical experience – and an MBA from two highly regarded European business schools.
International Track, 18 months / Fast-Track, 12 months / Part-Time, 24 months

2) Masters in Management in International Business:
Become a leader with a Master degree from two highly regarded European business schools.
Full-Time, 12 months

Program Highlights
Flexible and career enhancing programmes that paves the way for a career in management.

Eligibility: Graduates, Postgraduates


Correspondence Training Programme for Patent Agent Examination, 2015

Institute of Patent Attorneys, India (IPAI) is a unit of “INTELLECTUAL PROPERTY RESEARCH INSTITUTE (IPRI), NEW DELHI” and is providing professional training in Intellectual Property Rights for candidates to appear for Patent Agents Examination, conducted by Ministry of Commerce and Industry (Govt. of India) through Patent Offices and obtaining qualifications necessary to practice as a Patent Agent/Patent Attorney under the Patent Act and Rules.


Patent Agents/Attorneys

Patent Agents, also called Patent Attorneys are specialist legal advisors, similar to Lawyers, who advice their clients how to protect their intellectual property. Patent Attorneys work either in private firm of Patent Attorneys or in Patent Departments of large industrial Organizations. Patent Attorney’s day-to-day work generally involves drafting of patent specifications, making application for a patent, subsequent correspondence with the patent office on the objections raised; representing the applicant’s case at the hearings, filing opposition proceedings or defending an application against an opposition, all being of a highly technical nature is ordinarily entrusted to a qualified patent attorney. For the purpose of maintaining a high standard of efficiency and professional integrity the Patent Act has prescribed certain qualifications for persons practicing as Patent Attorneys and provided for their registration. Only person who satisfy those qualification and registered under the Patent Act are allowed to practice as Patent Attorneys in India.


Career Prospects  & Placement Services

Institute of Patent Attorneys Shall provides Placement assistance those who successfully cleared the Patent Agent Examination Conducted by the Controller of Patents. Patent Agents/Attorneys have ample number of job opportunities in Intellectual Property Law Firms, KPO/LPO, as well as Corporate Organizations. They can choose channels like in-house Advisors for different organizations or start their own Attorney’s Firms and Consultancy Services.


Degree in Pharmacy, Science, Engineering or Technology

Programme Details:-

First Stage: Printed study materials will be sending by courier/speed post immediately after joining the course. Study materials shall cover the syllabus.

Second Stage: Assignment

Class Room Training: 30 hours Class Room Training (5 Days) shall be conducted at IPAI, New Delhi, Hyderabad, Bangalore, Chennai, Mumbai, out station students can attend Skype.

The Last date for submitting the application: 15, June 2015.



Payment for registration can be done in either of the following TWO ways:
(i) Deposit Donation in any Oriental Bank of Commerce from anywhere in India by Cash/Net Banking in favour of INSTITUTE OF PATENT ATTORNEYS (IPA), INDIA,
A/c No. 1022-101-1000781,
IFS Code: ORBC0101022.
Oriental Bank of Commerce, Sector-10, Dwarka, New Delhi- 110 075

Cash Deposit Via any bank:
Go to “any nearby Bank” and ask for ‘NEFT Form” Fill the NEFT Form with the below account details INSTITUTE OF PATENT ATTORNEYS (IPA), INDIA,
A/c No. 1022-101-1000781,
IFS Code: ORBC0101022.
Oriental Bank of Commerce Sector-10, Dwarka, New Delhi- 110 075


E-mail the duly filled application form with passport size photographs pasted on it to:, with Cash Deposit slip/Transaction details.


Ist Floor, D-999, Sector-7, Dwarka , New Delhi-110 077,
Tel. 0 9810395199, 09388832525.

Faculty - Paramedical Lecturer / Professor in Client of 7 Colors Consultants

Our Client is one of the leader in Health Care /Medical Industry

Post: Faculty - Paramedical Lecturer / Professor

Career as Area Business Manager in Jenome Biophar

We, Jenome Biophar recognize itself as a business organization with a mission, not merely an entity that exists to generate profit. This mission describes the road map towards reaching long-term objectives and establishing the organization's future vision. Moreover, it highlights the basis and values that control business conduct on all levels.
Moreover, a clear future vision accessible to all company employees is an important element in portraying the desired shape of the organization in the future and therefore inspires, motivates and improves performance. This is why we keep our mission and vision in mind and heart at all times.
We, Jenome Oncology, are dedicated to anticancer range of products. We are dealing in almost all chemotherapeutic range of products as well as we also deal in unique & specialized anti cancer range of products. We are the pioneer in our special range of products which we had launched first time in India.

Post: Area Business Manager

Opportunity for Medical Representative in Leading Pharma Company Nextus Solution

Leading Pharma Company

Post: Medical Representative

Jaipur National University invites Faculty positions

Jaipur National University, Jaipur, a Private self- financed University, sponsored by Mahima Shiksha Samiti, Came into existence on October 22, 2007 through an Ordinance of the government of Rajasthan. Jaipur National University is one of the many institutions of the Seedling Group of educational Institutions of the Mahima Shiksha Samiti.

Invites applications for the posts of Professors/ Associate Professors/ Assistant Professors in the following disciplines

Post: Professors/ Associate Professors/ Assistant Professors



Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India

A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.


Subscribe to RSS headline updates from: